Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...

Investigators examine the relationship between sugar- and artificially- sweetened beverage intake and dementia risk in late ...

A long-term real-world study of older adults with COPD shows that initiation of tiotropium is linked to a minimal increase in ...

Diabetes drug semaglutide linked to reduced risk of dementia in type 2 diabetes patients Effects strongest in women and older ...

An analysis of 1.7 million patients shows semaglutide may significantly reduce Alzheimer and vascular dementia risk compared ...

A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could ...

With a growing global population and a greater proportion of people living over the age of 65, it is likely dementia cases ...

A new study finds that increasing your daily magnesium intake may slow brain aging and reduce the risk of dementia.

A new University of Hawaiʻi Cancer Center study has found that people who followed a dietary pattern known as the MIND diet ...

A new study published in the journal Neurology has found that drinking alcohol, even in relatively moderate amounts, ...

Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss ...

The research found that there was nearly a 50% increased risk of dementia among patients aged 55 and over who had used ...